Notice: 函数 WP_Styles::add 的调用方法不正确。 The style with the handle "storefront-woocommerce-style" was enqueued with dependencies that are not registered: storefront-style. 请查阅调试 WordPress来获取更多信息。 (这个消息是在 6.9.1 版本添加的。) in /wordpress/wp-includes/functions.php on line 6260

KB-1530

LAE102-hIgG1

Home » LAE102-hIgG1

Background of LAE102-hIgG1

ACVR2A is a type II member of the receptor Serine/Threonine kinases in the TGF β family. It serves as a receptor for Activin A, Activin B, and Inhibin A. Signaling by activins and BMPs is highly promiscuous. Apart from signaling through ALK4/7, the activin type II receptors (ACVR2A and ACVR2B) can also interact with several type I BMP receptors (ALK1/2/3/6), which can in turn form complexes with the type II BMP receptor, BMPRII. Type II receptors phosphorylate and activate type I receptors, which then autophosphorylate and bind and activate SMAD transcriptional regulators. ACVR2A can form complexes with different type I receptors that signal either to Smad2/3 (ALK4) or to Smad1/5/8 (ALK2, ALK3, ALK6). The different type I receptors compete for binding to ACVR2A, and this competition provides a mechanism that balances signaling between Activin A mediated, ALK4 dependent Smad2/3 signaling and BMP mediated ALK2 or ALK3 dependent signaling to Smad1/5/8. In myeloma cells, activin A treatment inhibits BMP 6 and BMP 9 induced activation of SMAD1/5/8 through ACVR2A/ACVR2B/ALK2.

Specifications

Catalog Number:
KB-1530
Antibody Name:
LAE102-hIgG1
Isotype:
FC Muations:
Wild-Type
Target:
ACVR2A
Species Reactivity:
Host Cell Line:
EXPICHO
Purification Method:
Affinity purified
Concentration:
>2 mg/mL
Formulation:
50 mM sodium citrate,150mM NaCl,pH5.5
Purity:
>95% by SDS-PAGE and SEC-HPLC
Validation:
Endotoxin Level:
<0.2 EU/mg as determined by the LAL method
Sterility:
0.2μm filtered
Storage:
It is recommended that the protein should be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Stability:
Stable for twelve months from date of receipt when stored at -20°C to -80°C;Stored at 2-8°C for one month without detectable loss of activity.

Characterization

Application

References

Oddrun Elise Olsen, et al. Activin A inhibits BMP signaling by binding ACVR2A and ACVR2B. Cell Commun Signal. 2015 Jun 6;13:27. V K Chin, et al. Inhibition of Activin A suppressed tumor necrosis factor α secretion and improved histopathological conditions in malarial mice. Trop Biomed. 2021 Mar 1;38(1):187 204. . Szabina Szófia Szilágyi, et al. Competition between type I activin and BMP receptors for binding to ACVR2A regulates signaling to distinct Smad pathways. BMC Biol. 2022 Feb 18;20(1):50. . Heather L Hayes, et al. A Pdx 1 Regulated Soluble Factor Activates Rat and Human Islet Cell Proliferation. Mol Cell Biol. 2016 Nov 14;36(23):2918 2930. .